An interventional study of repeated transcranial magnetic stimulation continuous theta-burst stimulation and SHAM repeated transcranial magnetic stimulation in Stroke, Hemiparesis and Transcranial Magnetic Stimulation, sponsored by University Hospital, Lille. Terminated at 1 site in France. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-05-15.
Sponsored by University Hospital, Lille · Not applicable, Interventional, and Basic science
Among 15 studies in Stroke by University Hospital, Lille — 4 open to participants now, 4 under way, none of them phase 3. Stroke · University Hospital, Lille.
Among the 15 studies in Stroke by University Hospital, Lille, this one is the only one that started in 2020, is one of 7 with no phase, and was the 8th registered.
8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.
This study's enrollment of 1 is below the median of 49 across 6,024 interventional studies indexed under Stroke.
Browse Stroke studies →4 of the 15 studies in Stroke by University Hospital, Lille are open now, in 1 country. Each count lists the studies.
Of the 1,415 Stroke studies recruiting now, 697 (49%) set no upper age limit and 280 (20%) stop at 75 or younger; 77 take children under 18; 196 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →15 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 1 started in 2020.
Median enrollment 30 across the 9 interventional studies, 421 across the 6 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
University Hospital, Lille is the lead sponsor of 631 studies on the registry; 142 are open to participants now.
1 of the studies in Stroke by University Hospital, Lille that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT02972008University Hospital, LilleIdentification of Epigenetic Risk Factors for Ischemic Complication During the TAVR Procedure in the Elderly | 2027-02 |
Among the 15 studies in Stroke by University Hospital, Lille, from their registry updates:
Nothing recorded among them since 2026-09-25.
This study evaluates the effect of a unique session of inhibitory rTMS (cTBS) over the contralesional posterio parietal cortex (PPC) on the spatio-temporal parameters of a pointing movement performed by stroke patients with their paretic upper limb. It will also assess the effects on the resting motor threshold of both hemispheres and on parietopremotor connectivity.
To achieve theses aims, the real cTBS stimulation will be randomly counterbalanced with a SHAM stimulation (in a second session) in a crossover design. Assessments will be performed before and after each stimulation session.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
continuous theta-burst TMS stimulation (1200 pulses, 50Hz, separated in two sequences of 600 pulses)
Device: repeated transcranial magnetic stimulation continuous theta-burst stimulation
SHAM stimulation
Device: SHAM repeated transcranial magnetic stimulation
cTBS
SHAM stimulation
Time of movement during the pointing movement
Time between the initiation of the movement and the reaching of the target
Time frame: 30 minutes
Reaction time (time between the go signal and th onset of the movement)
temporal parameters of pointing movements
Time frame: 30 minutes
Response time (time between the go signal and the reaching of the target)
temporal parameters of pointing movements
Time frame: 30 minutes
Peak velocity of the hand during the pointing movement
pak velocity in m/s
Time frame: 30 minutes
smoothness (number of units of movement during the pointing movement),
Spatial parameters of pointing movements
Time frame: 30 minutes
Linearity (ration between the length of the trajectory of the hand and the linear distance between the initial position of the hand and the target)
Spatial parameters of pointing movements
Time frame: 30 minutes
Detection of mirror movements with the healthy upper limb
EMG detection
Time frame: 30 minutes
Primary motor cortex excitability of both motor cortices
Resting motor threshold of lesioned and non-lesioned hemispheres
Time frame: 30 minutes
Parietomotor connectivity in the contralesional hemisphere
Assessed by a paired-pulse TMS protocol (see Allart et al. 2017 for more details)
Time frame: 30 minutes
Spatial bias
Line bisection test
Time frame: 30 minutes
Plan to share: No
No publications or documents are linked to this record.
Ran from Mar 2020 to primary completion in Aug 2021, 16 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.